Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM - News), announced today that it will be presenting at the New Cardiovascular Horizons and Management of the Diabetic Foot & Wound Healing (NCVH) conference in New Orleans September 10-13. NCVH is one of the largest multidisciplinary conferences in the country bringing together the leaders in the wound care market place. There are over 3500 expected attendees and one of the most distinguished faculty lists in the wound care industry. One of the featured speakers is Dr. Gary Rothenberg, DPM, Miami, FL who will present on Emerging Use of Topical "Biologics" in Limb Salvage: Role of "Activated Collagen" in Multimodality Treatments.

"We are excited about exhibiting at the NCVH conference and showcasing our products at the event," states Cathy Bradshaw, President of Wound Care Innovations. "It is an excellent opportunity to be with the industry leaders and promote our advanced wound care product, CellerateRx® especially at such a crucial point of our revenue generation cycle of the product."

The Company also has announced that they have expanded their sales team through the addition of Lisa DiRisio as Senior Account Manager. Lisa, who has significant experience in the wound care industry from her time at Smith & Nephew, will also be in attendance at the conference. Cathy Bradshaw further states, "We are very excited to have Lisa join our team and bring a wealth of value to the Company through her background and wound care relationships. Post our announcement of our independent studies of CellerateRX we have had multiple revenue leads and believe through the further build out of our team with individuals such as Lisa that we will be able to significantly expand our revenue generation in the near term."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTC Bulletin Board: WNDM - News), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at http://www.Celleraterx.com .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.